A Little Rock man with resistant kidney cancer is now in remission thanks to an experimental drug being tested at the University of Arkansas for Medical Sciences.
58-year-old Dwight Hamilton had been battling stage 4 liver cancer for four years before being declared cancer free. Hamilton receives the immunotherapy by infusion every few weeks while being closely monitored by staff. He has had no reported side effects or complications from the treatment. After only three doses, tumors in his chest had shrunk by 33%. Then, after 15 doses given over 11 months, his tumors completely disappeared.
The new form of immunotherapy was tested for the first time exclusively at UAMS in Arkansas and 45 other hospitals nationwide.
WebReadyTM Powered by WireReady® NSI